6/20/24 20:21 | 6/18/24 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | COO,CFO | P | 59 | 0.5911 | 0 | 100 | 26 | 480 | I | | | | | | | | | | | | | | |
3/28/24 18:05 | 3/27/24 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | COO,CFO | S | -7 | 1.16 | 0 | -6 | -1 | 473 | D | | | | | | | | | | | | | | |
11/14/23 18:24 | 11/13/23 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | COO,CFO | P | 113 | 0.5644 | 0 | 200 | 72 | 479 | I | | | | | | | | | | | | | | |
4/5/23 16:26 | 4/4/23 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | COO,CFO | P | 56 | 1.02 | 0 | 55 | 32 | 225 | I | | | | | | | | | | | | | | |
3/22/23 17:17 | 3/20/23 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | COO,CFO | P.d | 48 | 0.9687 | 0 | 50 | 42 | 170 | I | | | | | | | | | | | | | | |
7/15/22 16:23 | 7/15/22 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | COO,CFO | P | 100 | 7.21 | 0 | 14 | 13 | 120 | I | | | | | | | | | | | | | | |
3/24/22 16:53 | 3/23/22 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | COO,CFO | S | -96 | 8.92 | 0 | -11 | -9 | 106 | D | | | | | | | | | | | | | | |
3/25/21 16:11 | 3/23/21 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | CFO | S | -52 | 9.48 | 0 | -5 | -4 | 117 | D | | | | | | | | | | | | | | |
10/14/20 19:27 | 10/14/20 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | CFO | P | 30 | 10.01 | 0 | 3 | 4 | 78 | I | | | | | | | | | | | | | | |
6/23/20 17:01 | 6/23/20 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | CFO | P | 26 | 12.96 | 0 | 2 | 3 | 75 | I | | | | | | | | | | | | | | |
12/3/19 18:46 | 12/3/19 | PTGX | Protagonist Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | D | | P | 46 | 5.70 | 0 | 8 | 80 | 18 | I | | | | | | | | | | | | | | |
9/26/19 16:08 | 9/26/19 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | CFO | P | 19 | 16.78 | 0 | 1 | 5 | 26 | I | | | | | | | | | | | | | | |
6/3/19 16:03 | 5/30/19 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | CFO | P | 19 | 18.70 | 0 | 1 | 4 | 25 | I | | | | | | | | | | | | | | |
2/12/19 17:33 | 2/12/19 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | O | CFO | P.d | 96 | 16.00 | 0 | 6 | 34 | 24 | D | | | | | | | | | | | | | | |
5/17/18 17:48 | 5/16/17 | PTGX | Protagonist Therapeutics, Inc | | Health | Drug | Pharmaceutical Preparations | Giraudo Bryan | CA | D | | P.d | 65 | 6.46 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |